Literature DB >> 7711418

Interaction of allopurinol and hydrochlorothiazide during prolonged oral administration of both drugs in normal subjects. I. Uric acid kinetics.

W Löffler1, R Landthaler, J X de Vries, I Walter-Sack, A Ittensohn, A Voss, N Zöllner.   

Abstract

The interaction of allopurinol (300 mg/day) and hydrochlorothiazide (50 mg/day) was studied in seven healthy male volunteers during prolonged coadministration of the two drugs using defined dietary conditions. A formula diet was administered with the allopurinol throughout the 24-day study, while hydrochlorothiazide was added during days 11-21. After the addition of hydrochlorothiazide both plasma uric acid and plasma oxipurinol rose for 6 days--24% and 30%, respectively, compared to steady-state levels during allopurinol alone (P < 0.01 each). In neither substance were variations in renal excretion significant. By the end of combined treatment (day 21), the changes induced by hydrochlorothiazide had already been reversed to a considerable extent. It is concluded that both in normal individuals and in patients with normal renal clearance of uric acid the effect of hydrochlorothiazide on the plasma concentration and renal excretion of oxipurinol is small. When taking both drugs, there is no increased risk during long-term treatment, and a risk is even questionable during the first days.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7711418     DOI: 10.1007/bf00577758

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  32 in total

1.  Dosage prescribing and plasma oxipurinol levels in patients receiving allopurinol therapy.

Authors:  G M Peterson; R R Boyle; H W Francis; N W Oliver; J Paterson; R J von Witt; G R Taylor
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  The allopurinol hypersensitivity syndrome: its relation to plasma oxypurinol levels.

Authors:  E Casas; J G Puig; F A Mateos; M L Jiménez; A D Michán; T H Ramos
Journal:  Adv Exp Med Biol       Date:  1989       Impact factor: 2.622

3.  Renal clearance of oxipurinol, the chief metabolite of allopurinol.

Authors:  G B Elion; T F Yü; A B Gutman; G H Hitchings
Journal:  Am J Med       Date:  1968-07       Impact factor: 4.965

4.  Tolerance and ionic effects in hypertensive patients of prolonged administration of an aldosterone antagonist (amiloride) as compared with a thiazide.

Authors:  J C Demanet; P Paduart; J P Fichefet; C Delcroix
Journal:  J Clin Pharmacol J New Drugs       Date:  1970 Jul-Aug

5.  Changes in intrarenal uric acid handling during chronic spironolactone treatment in patients with essential hypertension.

Authors:  J C Roos; P Boer; K H Peuker; E J Dorhout Mees
Journal:  Nephron       Date:  1982       Impact factor: 2.847

6.  Clinical study of ticrynafen. A new diuretic, antihypertensive, and uricosuric agent.

Authors:  M Nemati; M C Kyle; E D Freis
Journal:  JAMA       Date:  1977-02-14       Impact factor: 56.272

7.  Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency.

Authors:  K R Hande; R M Noone; W J Stone
Journal:  Am J Med       Date:  1984-01       Impact factor: 4.965

8.  [Time course of oxipurinol levels in plasma following single dose and chronic administration of allopurinol in different pharmaceutical preparations (author's transl)].

Authors:  I Walter-Sack; W Gröbner; N Zöllner
Journal:  Arzneimittelforschung       Date:  1979

9.  Prevention of calcium nephrolithiasis with low-dose thiazide, amiloride and allopurinol.

Authors:  G Maschio; N Tessitore; A D'Angelo; A Fabris; F Pagano; A Tasca; G Graziani; A Aroldi; M Surian; G Colussi; A Mandressi; A Trinchieri; F Rocco; C Ponticelli; L Minetti
Journal:  Am J Med       Date:  1981-10       Impact factor: 4.965

10.  Multicentre comparative trial of tienilic acid and hydrochlorothiazide in hypertensive patients.

Authors:  C Ponticelli; A Lechi; T di Perri; B Redaelli; F Locatelli; E Rivolta; G Covi; G L Messa; G Pincella; L Pedrini; M Recchia; P Gouère
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

View more
  4 in total

1.  Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteers.

Authors:  Daniel Y Ng; Sophie L Stocker; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Eur J Clin Pharmacol       Date:  2010-12-23       Impact factor: 2.953

2.  Interaction of allopurinol and hydrochlorothiazide during prolonged oral administration of both drugs in normal subjects. II. Kinetics of allopurinol, oxipurinol, and hydrochlorothiazide.

Authors:  J X de Vries; A Voss; A Ittensohn; I Walter-Sack; W Löffler; R Landthaler; N Zöllner
Journal:  Clin Investig       Date:  1994-12

Review 3.  Urate Handling in the Human Body.

Authors:  David Hyndman; Sha Liu; Jeffrey N Miner
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

4.  Impact of diuretics on the urate lowering therapy in patients with gout: analysis of an inception cohort.

Authors:  Laura Ranieri; Carolina Contero; Maria-Luisa Peral; Irene Calabuig; Pedro Zapater; Mariano Andres
Journal:  Arthritis Res Ther       Date:  2018-03-22       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.